NeoGenomics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.07 |
Market Cap |
$2.39 B |
Shares Outstanding |
102.47 M |
Public Float |
88.66 M |
Address |
12701 Commonwealth Drive Fort Myers Florida 33913 United States |
Employees | - |
Website | http://www.neogenomics.com |
Updated | 07/08/2019 |
NeoGenomics, Inc. provides cancer diagnostics and pharma services. It operates through a network of cancer focused testing laboratories to provide genetic and molecular testing services. It offers various testing services, including Cytogenetics, Fluorescence In-Situ Hybridization, Flow Cytometry, Immunohistochemistry, Molecular testing and Pathology consultation. |